About Aptadel Therapeutics
Aptadel Therapeutics is a Healthcare company based in Barcelona (Spain) founded in 2020 by Oscar MartÃnez Tirado. It develops RNA Aptamer technologies for targeted cancer drug delivery. It operates on a B2B model. Aptadel Therapeutics offers products and services including RNA Aptamer Technology. Its focus areas include Biotechnology, Oncology, RNA Technologies and Life Sciences. Its competitors include SpringWorks Therapeutics, QSAM Biosciences, Vuja De Sciences, ECM Therapeutics and Atlanthera and 3 more; 4 of its 8 listed competitors have raised funding.
Company details
Aptadel Therapeutics is a biotech company that creates RNA Aptamer technologies to deliver therapeutics into cancer cells, focusing on conditions like Ewing Sarcoma. As a pre-clinical stage firm, it customizes tools for siRNA, miRNA, and other agents across oncology indications. The company, a spin-off from IDIBELL and co-founded by Fundación Alba, operates from Barcelona, Spain, aiming to advance treatments through research and partnerships.
- Headquarters Barcelona, Spain
- Founders Oscar Martínez Tirado
- SectorsHealthcare
- Email••••••••
- Website aptadeltx.com
- Social LinkedIn X
Products & Services of Aptadel Therapeutics
Aptadel Therapeutics offers a comprehensive portfolio of products and services, including RNA Aptamer Technology.
Tool for delivering therapeutics like siRNA into cancer cells
People of Aptadel Therapeutics
2 people are tracked at Aptadel Therapeutics (2 in leadership).
| Name | Role | Group |
|---|---|---|
Oscar Martínez Tirado | Co-Founder | Leadership |
Oscar Martinez Tirado | Founder and scientific advisor | Leadership |
Complete people profiles for Aptadel Therapeutics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Aptadel Therapeutics
Aptadel Therapeutics has 8 listed competitors in our database, 4 of them funded. They include SpringWorks Therapeutics, QSAM Biosciences, Vuja De Sciences, ECM Therapeutics and Atlanthera, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| springworkstx.com | 2017 | New York, United States | $229.6M | 305 | Small molecule therapeutics are developed for cancer and rare diseases. | |
| qsambio.com | 2004 | Palm Beach, United States | – | 4 | Developer of nuclear medicines for the treatment of bone cancer treatment & bone marrow ablation | |
| vujade-life.com | 2017 | Hoboken, United States | $3.94M | – | Therapies for preventing cancer metastasis and recurrence are developed. | |
| ecmtherapeutics.com | 2018 | Warrendale, United States | $26.1M | – | Diagnostic and therapeutic products from extracellular matrix are developed. | |
| atlanthera.com | 2010 | Saint Herblain, France | $1.11M | – | Small molecule drugs for bone diseases and tumors are developed. | |
| taithera.com | 2016 | New York, United States | – | – | Nanomedicine platform for targeted bone drug delivery is developed. | |
| flashthera.com | 2019 | Yokohama, Japan | – | – | Novel therapeutics are developed to treat acute myeloid leukemia. | |
| cartilago.it | 2018 | Maglie, Italy | – | – | Molecular technology for regenerative medicine is developed by Cartilago. |
Detailed competitors of Aptadel Therapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Clinical Trials & Research Tech
10 companies that operate in the same segment as Aptadel Therapeutics (Clinical Trials & Research Tech), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Genetic services are provided by Colossal's laboratory operations. | 2021 | Austin, Texas, United States | USD 617.6 M | – | – | |
Research lab engaged in pharmacological measurements on therapeutic protein variants | 2018 | United States | USD 78.19 M | – | 22 | |
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare. | 2004 | Ahmedabad, Gujarat, India | – | USD 50.52 M | 902 | |
Generic injectables for oncology and anesthesiology are manufactured. | 1989 | Hyderabad, Telangana, India | – | USD 4.22 M | 228 | |
Medical research labs are provided by GALY for scientific purposes. | 2018 | Boston, Massachusetts, United States | USD 61.59 M | – | 25 | |
Laboratory focused on biotechnology & molecule research services | 2018 | Cambridge, Massachusetts, United States | USD 32.68 M | – | – | |
Laboratory delivers discovery & research in nuclear and particle physics | 1947 | United States | – | – | 2,436 | |
Research and manufacturing of hemp products are conducted by BRC. | 2017 | Monterey, California, United States | USD 25.26 M | – | 16 | |
Genome sequencing studies are conducted for medical research purposes. | 2020 | Cambridge, Cambridgeshire, United Kingdom | USD 11.26 M | – | 12 | |
Novel immunotherapy therapeutic targets are discovered through laboratory research. | 2019 | Branford, Connecticut, United States | USD 92 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Aptadel Therapeutics
Complete news archive for Aptadel Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aptadel Therapeutics
Aptadel Therapeutics was founded in 2020.
Aptadel Therapeutics is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.
Aptadel Therapeutics is a biotech company that creates RNA Aptamer technologies to deliver therapeutics into cancer cells, focusing on conditions like Ewing Sarcoma. As a pre-clinical stage firm, it customizes tools for siRNA, miRNA, and other agents across oncology indications. The company, a spin-off from IDIBELL and co-founded by Fundación Alba, operates from Barcelona, Spain, aiming to advance treatments through research and partnerships.
Aptadel Therapeutics's top competitors include SpringWorks Therapeutics, Vuja De Sciences and QSAM Biosciences.
Aptadel Therapeutics offers RNA Aptamer Technology.